Patent Yard Sign in
Canadian application, no grantCanada

Treatment for pulmonary fibrosis

CA 2285350 A1 · Owner: Agricultural Research Organization, Ministry Of Agriculture · Inventors: Nagler, Arnon; Pines, Mark

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A composition for treating pulmonary fibrosis and a method of using and manufacturing the composition are provided. The composition includes a quinazolinone derivative, preferably Halofuginone. The preferred method of administration is by inhalation, preferably with a pharmaceutically acceptable carrier in the form of an aerosol.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 31, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 31, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 31, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 31, 1997
GrantedNo grant recorded
Term endedMarch 31, 2017
Patent numberCA 2285350 A1
Classification (IPC)A61K31/50 +1 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedMarch 31, 1997Term endedMarch 31, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.